ReBorn (1050nm)
Apr 2024
123d
Lightfective , Ltd. has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Laser For Disruption Of Adipocyte Cells For Aesthetic Use . Use the specialty filter in the sidebar to narrow results.